Drug Type Synthetic peptide |
Synonyms IGF-II (69-84) |
Target |
Action stimulants |
Mechanism IGF-1 stimulants(Insulin-like growth factor I stimulants), IGF-2 stimulants(Insulin-like growth factor II stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | - | - | 06 Dec 2025 |
| Breast Cancer | Preclinical | - | - | 06 Dec 2025 |






